Sarawak General Hospital Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2016
NCT02783859
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Sarawak General Hospital

Active Ingredients

Drugs in Phase 4 Trials (3)

clavulanate (Augmentin) (2 trials)

procaine benzylpenicillin (novocaine) (1 trial)

vildagliptin (1 trial)

Drugs in Other Trials (3)

amoxicillin (1 trial)

urea (1 trial)

vitamin e (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus, Type 2 (Phase 4)

Pneumonia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 6